Gynuity Health Projects

Resources

Misoprostol added to the WHO Model List of Essential Medicines for the Treatment of PPH

Misoprostol for the treatment of postpartum hemorrhage (PPH) was added to the World Health Organisation’s 19th Model List of Essential Medicines (EML). This one-page document summarizes the decision reached by the 20th Expert Committee on the Selection and Use of Essential Medicines when in April 2015 it met at the WHO Headquarters in Geneva to revise and update the EML for both adults and children.

A "text only" version is available for users with slower internet connections.

Open Text Version in New Window

Download PDF version:

Download

Download eBook version:

EPUB format for iPad, Nook, and
Sony Reader.

Download